Ethyl 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylate
CAS: 161797-99-5
Rif. TR-E918910
250mg | 94,00 € |
Informazioni sul prodotto
- 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylic Acid Ethyl Ester
- Ethyl 2-(4-Hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
- 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate
- 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
- 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxytic acid ethyl ester
- 5-Thiazolecarboxylic acid, 2-(4-hydroxyphenyl)-4-methyl-, ethyl ester
- Ethyl 2-(4-HydroxyPhenyl)-4-Methyl Thiazole-5-Carboxylate
- Ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
- Ethyl-2-(4-Hydroxyphenyl)-4-Methyl-5-Thiazolecarboxylate
- Ethyl2-(4-hydroxy phenyl)-4-methylthiazole-5-carboxylate
- Vedi altri sinonimi
- Febuxostat N-2
Applications Ethyl 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylate is used in the synthesis of the major metabolites of Febuxostat (F229000), a xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout.
References Li, X., et. al.: Lett. Org. Chem., 12, 217 (2015); Vallu, V., et. al.: Anal. Chem. Indian J., 14, 339 (2014); Osada, Y., et al.: Eur. J. Pharmacol., 241, 183 (1993); Okamoto, K., et al.: J. Biol. Chem., 278, 1848 (2003); Mayer, M.D., et al.: Am. J. Therap., 12, 22 (2005); Tomlinson, B., et al.: Curr. Opin. Invest. Drugs, 6, 1168 (2005)
Proprietà chimiche
Richiesta tecnica su: TR-E918910 Ethyl 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylate
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.